Women in Science: UCB’s Iris Loew-Friedrich: ‘patients are what get me out of bed every morning’ 16-Aug-2023 By Isabel Cameron Iris Loew-Friedrich is the executive vice president and chief medical officer at global biopharma company UCB.
UCB commits €300m to biologics manufacturing plant 08-Jan-2020 By Nick Taylor UCB outlines plans to invest €300m in Belgian biologics plant, creating 150 jobs.
GSK backs up genomics refocus with UCB partnership 13-Jun-2019 By Ben Hargreaves GSK signs partnership deal with the University of California to advance genomic research, which sees the creation of a lab and funding for five years of research.